title: Drug approvals: '08 in review. Certolizumab pegol (Cimzia).
authors.affiliation: Oregon Health and Science University, Portland, Ore., USA.
authors.forename: Gary
authors.initials: G
authors.lastname: Laustsen
authors.forename: Fernando
authors.initials: F
authors.lastname: Carrillo
authors.forename: Jessica
authors.initials: J
authors.lastname: Johnson
authors.forename: Cynthia
authors.initials: C
authors.lastname: Smith
mesh_terms: D061067:Antibodies, Monoclonal, Humanized; D000068582:Certolizumab Pegol; D003424:Crohn Disease / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000494:pharmacology / Q000627:therapeutic use*; D011092:Polyethylene Glycols / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D005765:Gastrointestinal Agents; D007140:Immunoglobulin Fab Fragments; D011092:Polyethylene Glycols; D000068582:Certolizumab Pegol